Interview with Warren Chen, Country Manager, Celgene Taiwan
Could you please give our readers an overview of the importance of Taiwan for Celgene in a regional and a global context? What is attractive in Taiwan for Celgene? Celgene…
In order to obtain genetic information for analysis and their applications for developing new drugs, precise and qualitative nucleic acid extraction steps are essential. This is Viogene’s primary focus. Viogene provides innovative and cutting-edge nucleic acids extraction technologies and products to allow scientists achieve their goals. Viogene currently has more than 40 nucleic acids extraction products for extracting nucleic acids from various biological sources such as animals, plants, microorganisms. Viogene sells its products in more than 30 countries worldwide.
Another part of Viogene’s research and development program is a platform of G protein coupled receptors (GPCRs) related drugs screening from traditional Chinese medicines (TCMs), GPCRs have proved to be very successful drug targets for more than 30% of marketed drugs which target directly or indirectly on GPCRs, which including the top 100 brand name prescription drugs, however mitigating side effects and increasing potency of GPCRs related drugs are marketed needed, Viogene’s GPCRs new drug screening and discovering programs from TCMs offer new solutions and opportunities for achieving the goals.
No.276, Ta-Tung Rd., Sec.1, Shijr,
New Taipei City, Taiwan
PHONE: 886 2 26472259
FAX: 886 2 26475094
Website: www.viogene.com
Could you please give our readers an overview of the importance of Taiwan for Celgene in a regional and a global context? What is attractive in Taiwan for Celgene? Celgene…
Novo Nordisk is one of the few pharmaceutical multinationals focused in one key therapeutic area. Perhaps you could start by telling our readers about how diabetes has evolved in Taiwan…
Please tell our readers about the importance of GSK Taiwan within the context of the company’s global operations, and also what there is in Taiwan that makes it so attractive…
Medigen was created in 1999 and is a listed company. How did the vision for the company come about, and what was it that attracted today’s main shareholders to Medigen?…
Please describe the activities of the IRPMA to our readers, and explain the membership advantages of your association. Today the IRPMA consists of 37 multinational research-based pharmaceutical manufacturers, as well…
The Development Centre for Biotechnology was founded in 1984 as a tool for connecting biotechnological academia to the Taiwanese industry and promoting the strengths of Taiwan’s biopharmaceutical sector to the…
Please explain the factors that led to the creation of the Taiwan Intellectual Property Office, and its main activities today. For the Taiwanese government, intellectual property (IP) rights are very…
Genovate was founded in 1995. It is a very interesting story: a mix of biotech, the history with American company Genelabs, government investments and also private investment through Chinachem. Can…
See our Cookie Privacy Policy Here
